Indication expansion of existing and newly developed drug
Our exhaustive biomarker profiling of the drug and intended indications coupled with our unique fish-net approach enables the quantification of relative relevance of the drug to effective treatment response in other indications.
Recommendations of potential disease areas/patient groups for expansion including justifications based on clients’ requirement can be provided.
Impact & Benefits
Expansion of the clients’ portfolio with a market differentiating drug product showing superior efficacy in different indications/patient groups especially in combination therapy approaches
Preserving value of the client's novel molecule via clinical rescue
Value addition to shelved clinical trial assets
Market exclusivity via 505(b)(2) regulatory pathway